- Home
- LPTX vs ATER Comparison
LPTX vs ATER Comparison
Compare LPTX & ATER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LPTX
- ATER
- Stock Information
- Founded
- LPTX 2011
- ATER 2014
- Country
- LPTX United States
- ATER United States
- Employees
- LPTX N/A
- ATER N/A
- Industry
- LPTX Biotechnology: Biological Products (No Diagnostic Substances)
- ATER Home Furnishings
- Sector
- LPTX Health Care
- ATER Consumer Discretionary
- Exchange
- LPTX Nasdaq
- ATER Nasdaq
- Market Cap
- LPTX 14.7M
- ATER 15.5M
- IPO Year
- LPTX N/A
- ATER N/A
- Fundamental
- Price
- LPTX $0.31
- ATER $1.26
- Analyst Decision
- LPTX Hold
- ATER
- Analyst Count
- LPTX 1
- ATER 0
- Target Price
- LPTX N/A
- ATER N/A
- AVG Volume (30 Days)
- LPTX 661.1K
- ATER 66.5K
- Earning Date
- LPTX 08-19-2025
- ATER 08-13-2025
- Dividend Yield
- LPTX N/A
- ATER N/A
- EPS Growth
- LPTX N/A
- ATER N/A
- EPS
- LPTX N/A
- ATER N/A
- Revenue
- LPTX N/A
- ATER $94,191,000.00
- Revenue This Year
- LPTX N/A
- ATER N/A
- Revenue Next Year
- LPTX N/A
- ATER $7.48
- P/E Ratio
- LPTX N/A
- ATER N/A
- Revenue Growth
- LPTX N/A
- ATER N/A
- 52 Week Low
- LPTX $0.22
- ATER $1.15
- 52 Week High
- LPTX $4.79
- ATER $3.84
- Technical
- Relative Strength Index (RSI)
- LPTX 43.86
- ATER 43.43
- Support Level
- LPTX $0.30
- ATER $1.16
- Resistance Level
- LPTX $0.37
- ATER $1.21
- Average True Range (ATR)
- LPTX 0.03
- ATER 0.05
- MACD
- LPTX -0.00
- ATER 0.00
- Stochastic Oscillator
- LPTX 28.53
- ATER 44.00
About LPTX Leap Therapeutics Inc.
Leap Therapeutics Inc is a biopharmaceutical company developing novel biomarker-targeted antibody therapies designed to treat patients with cancer by inhibiting fundamental tumor-promoting pathways, targeting cancer-specific cell surface molecules, and harnessing the immune system to attack cancer cells. The company's key clinical-stage drug candidate is sirexatamab (DKN-01), which targets Dickkopf-related protein 1 (DKK1) and is being studied in a clinical trial in patients with colorectal cancer. In addition, it also has a preclinical program to develop a proprietary monoclonal antibody, called FL-501 which works by inhibiting the GDF-15 protein.
About ATER Aterian Inc.
Aterian Inc is a technology-enabled consumer products company. Its product categories include home and kitchen appliances, kitchenware, environmental appliances (dehumidifiers and air conditioners), beauty-related products and, consumer electronics. It has various owned and operates brands, including HomeLabs, Squatty Potty, Healing Solutions, PurSteam, and others. The company generates revenue through the online sales of various consumer products that are sold online.